Evolut Low-Risk Study at Three Years: Clinical Benefit or Statistical Fallacy
A review of the three-year outcomes of the Evolut Low-Risk study and comparison with the published follow-up at one and two years.
A review of the three-year outcomes of the Evolut Low-Risk study and comparison with the published follow-up at one and two years.
A bicentric retrospective study adjusted by propensity score analysis examining 2-year outcomes of percutaneous edge-to-edge therapy compared to surgical intervention for functional mitral regurgitation.
The American Society of Thoracic Surgeons (STS) registry analyzed 6,507 patients who underwent isolated tricuspid valve surgery.
This systematic review and meta-analysis is the first study to independently evaluate the mid-term outcomes (5 years) of isolated aortic valve replacement using the Perceval sutureless prosthesis.
A retrospective analysis of aortic valve reimplantation outcomes over the last 20 years, using the “Valsalva graft” at the center that introduced its clinical application.
Patient-level meta-analysis comparing survival outcomes of TAVI vs. aortic valve replacement across different approaches: sternotomy and, innovatively, minimally invasive approach.
The COAPT study’s 5-year outcomes assess clinical parameters and mortality in patients with severe secondary mitral regurgitation (MR) after MitraClip implantation.
This study is a randomized, multicenter, prospective, open clinical trial comparing clinical outcomes 3 months after implanting an On-X mechanical mitral prosthesis in patients with standard anticoagulation ranges versus a lower target.
This is a multicenter, randomized clinical trial evaluating outcomes of transcatheter edge-to-edge tricuspid valve repair compared to optimized medical management in 350 patients with severe tricuspid regurgitation.
Analysis of post-procedure outcomes and mid-term follow-up of TAVI vs. SVA in a U.S. healthcare insurance database for patients with pure aortic insufficiency.